V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20161037 | 20062179 | 1.85 | 66.6 | Neo-adjuvant (N) | 2019-03-28 | 2019-04-04 | ECX | N | N | ECX | 100965731 |
| 20161038 | 20062180 | 1.75 | 110 | Palliative (P) | 2018-07-30 | 2018-08-06 | ECX | N | N | ECX | 101485965 |
| 20161040 | 20062181 | null | 180 | Neo-adjuvant (N) | 2017-06-26 | 2017-07-07 | ECX | N | N | ECX | 100446450 |
| 20161044 | 20062182 | 1.65 | 54.65 | null | null | null | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100802155 |
| 20161045 | 20062183 | 1.86 | 55 | Neo-adjuvant (N) | 2017-11-01 | 2017-11-04 | ECX | N | N | ECX | 100808246 |
| 20161048 | 20062184 | 1.6 | 64.5 | Curative (C) | 2017-01-25 | 2017-02-03 | ECX | N | N | ECX | 100938883 |
| 20161052 | 20062185 | 1.86 | 56.4 | Palliative (P) | 2016-11-19 | 2016-12-10 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101751181 |
| 20161054 | 20062186 | 1.58 | 64.1 | Palliative (P) | 2018-12-08 | 2018-12-23 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101102267 |
| 20161055 | 20062187 | 1.75 | 52.8 | Neo-adjuvant (N) | 2015-08-06 | 2015-08-25 | ECX | N | N | ECX | 100482975 |
| 20161056 | 20062188 | 1.6 | 47.5 | Palliative (P) | 2018-04-12 | 2018-04-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100252018 |
| 20161058 | 20062189 | 1.78 | 36 | Palliative (P) | 2019-03-09 | 2019-03-24 | ECX | N | N | ECX | 101578962 |
| 20161059 | 20062190 | 1.81 | 68.7 | Palliative (P) | 2017-12-05 | 2017-12-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100012035 |
| 20161063 | 20062191 | 1.54 | 73.7 | Neo-adjuvant (N) | 2019-09-18 | 2019-09-20 | ECX | N | null | ECX | 101690347 |
| 20161066 | 20062192 | 1.74 | 77.1 | Adjuvant (A) | 2018-10-28 | 2018-11-04 | ECX | null | N | ECX | 100941324 |
| 20161069 | 20062193 | 1.72 | 75.5 | Adjuvant (A) | 2017-03-01 | 2017-03-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100465868 |
| 20161070 | 20062194 | 1.58 | 69 | Palliative (P) | 2017-09-22 | 2017-09-27 | Gemcitabine + Capecitabine | null | N | ECX | 101085989 |
| 20161071 | 20062195 | 1.65 | 87.3 | Adjuvant (A) | 2016-12-23 | 2016-12-24 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 101303597 |
| 20161072 | 20062196 | null | null | Palliative (P) | 2016-08-31 | 2016-09-19 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101356847 |
| 20161073 | 20062197 | 1.6 | 51.3 | Neo-adjuvant (N) | 2016-07-15 | 2016-08-05 | ECX | N | null | ECX | 100544335 |
| 20161074 | 20062198 | 1.56 | 55.1 | Neo-adjuvant (N) | 2016-09-18 | 2016-09-20 | ECX | null | N | ECX | 101298410 |
| 20161076 | 20062199 | 1.66 | 60 | Adjuvant (A) | 2017-01-20 | 2017-02-01 | ECX | null | N | ECX | 100889362 |
| 20161077 | 20062200 | 1.69 | 86 | Not known (9) | 2018-11-22 | 2018-11-28 | ECX | N | null | ECX | 101779644 |
| 20161081 | 20062201 | 1.79 | 75.5 | Palliative (P) | 2017-04-08 | 2017-05-04 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101374935 |
| 20161082 | 20062202 | 1.8 | null | Adjuvant (A) | 2018-11-29 | 2018-12-14 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100660241 |
| 20161084 | 20062203 | 1.77 | 79.1 | Palliative (P) | 2018-10-01 | 2018-10-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100446560 |
| 20161090 | 20062204 | 1.79 | 58 | Neo-adjuvant (N) | 2016-12-09 | 2016-12-15 | ECX | 2 | null | ECX | 100462252 |
| 20161091 | 20062205 | 1.64 | 81.5 | Neo-adjuvant (N) | 2018-09-24 | 2018-09-24 | ECX | N | N | ECX | 100015715 |
| 20161092 | 20062206 | 1.87 | 55.4 | Neo-adjuvant (N) | 2019-09-06 | 2019-09-19 | ECX | N | N | ECX | 101857418 |
| 20161096 | 20062207 | 1.66 | 61 | Palliative (P) | 2016-10-15 | 2016-10-18 | ECX | 2 | N | ECX | 100369241 |
| 20161097 | 20062208 | 1.61 | 102 | null | 2018-10-21 | 2018-11-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101517243 |
| 20161099 | 20062209 | 1.78 | 100.7 | Neo-adjuvant (N) | 2017-07-23 | 2017-08-03 | ECX | N | N | ECX | 101838076 |
| 20161100 | 20062210 | 1.67 | 77 | Neo-adjuvant (N) | 2016-05-07 | 2016-05-12 | ECX | null | N | ECX | 100404061 |
| 20161101 | 20062211 | 1.88 | 70.5 | Curative (C) | 2016-12-10 | 2017-01-04 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100227465 |
| 20161102 | 20062212 | 1.59 | 76.3 | Neo-adjuvant (N) | 2019-03-10 | 2019-03-13 | ECX | N | N | ECX | 100499588 |
| 20161103 | 20062213 | 1.6 | 103.2 | Palliative (P) | 2017-08-13 | 2017-08-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101060320 |
| 20161104 | 20062214 | 1.65 | 51.4 | Palliative (P) | 2016-04-27 | 2016-05-07 | ECX | N | N | ECX | 100228774 |
| 20161105 | 20062215 | 1.6 | 78.2 | Neo-adjuvant (N) | 2016-04-01 | 2016-06-04 | ECX | 02 | N | ECX | 101766257 |
| 20161106 | 20062216 | 1.68 | 75.8 | Palliative (P) | 2019-09-13 | 2019-09-24 | ECX | N | N | ECX | 101214785 |
| 20161108 | 20062217 | 1.59 | 58.4 | Adjuvant (A) | 2018-07-01 | 2018-07-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100881280 |
| 20161110 | 20062218 | 1.72 | 57.9 | Palliative (P) | 2019-11-20 | 2019-12-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101440525 |
| 20161112 | 20062219 | 1.8 | 79.8 | Neo-adjuvant (N) | 2018-01-19 | 2018-02-06 | ECX | N | N | ECX | 101595799 |
| 20161113 | 20062220 | null | 105.4 | Neo-adjuvant (N) | 2016-07-15 | 2016-08-01 | ECX | N | null | ECX | 100836696 |
| 20161114 | 20062221 | 1.83 | 59 | Adjuvant (A) | null | 2019-10-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100195341 |
| 20161116 | 20062222 | 1.75 | 78.9 | Palliative (P) | 2018-06-14 | 2018-06-22 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101049788 |
| 20161117 | 20062223 | 1.59 | 56.9 | Adjuvant (A) | null | 2018-02-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101847725 |
| 20161118 | 20062224 | 1.8 | 102 | Palliative (P) | 2017-11-04 | 2017-11-04 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101375817 |
| 20161120 | 20062225 | 1.79 | 95 | Neo-adjuvant (N) | null | 2018-11-22 | ECX | N | null | ECX | 100734105 |
| 20161121 | 20062226 | 1.77 | 74.5 | Palliative (P) | 2017-03-05 | 2017-03-05 | ECX | 2 | N | ECX | 100960937 |
| 20161123 | 20062227 | 1.59 | 48.1 | Palliative (P) | 2017-11-20 | 2017-11-22 | ECX | 02 | N | ECX | 101651608 |
| 20161124 | 20062228 | 1.8 | 88 | Disease modification (D) | 2019-04-19 | 2019-05-04 | ECX | N | N | ECX | 100686400 |